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EDITORIAL
ALS:  Control  ventilation,  manage  respiratory
secretions and,  when  required,  oversee  the  process  of
dying
ELA:  controlar  a  ventilac¸ão,  manobrar  as  secrec¸ões  respiratórias  e,  quando
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ALS  is  a  neurodegenerative  disease  which  leads  to  progres-
sive  paralysis.  While  there  is  no  cure  for  ALS,  treatment
is  available  and,  as  recently  said  to  us  a  board  mem-
ber  of  a  Spanish  ALS  patient  association,  ‘‘our  doctor  is
the  pulmonologist’’.  This  is  true,  but  only  to  an  extent.
The  contribution  of  a  neurologist  and  other  professionals
is  essential  for  the  management  of  some  of  the  problems
which  damage  quality  of  life  of  patients  and  their  relatives.1
Moreover,  respiratory  care  teams  are  committed  to  move
treatment  away  from  the  environment  of  palliative  care,  for
those  patients  who  desire  this,  and  move  it  towards  what  A.
Oppenheimer  called  ‘‘high  technology  and  compassionate
care.’’  Yet,  we  must  also  prevent  dyspnoea  and  any  other
kind  of  suffering  for  those  patients  who  refuse  life-sustaining
treatment.
The  old  statistics  on  the  survival  of  ALS  patients  are
no  longer  valid  because  their  lives  can  now  be  prolonged
--  without  damaging  quality  of  life  and  even  improving  it
--  thanks  to  the  respiratory  muscle  aids  now  in  use:  aids
for  the  maintenance  of  adequate  alveolar  ventilation  and
the  appropriate  management  of  pulmonary  secretions.  Non-
invasive  procedures  have  demonstrated  their  ability  to  have
a  positive  effect  on  the  prognosis  of  these  patients  and  they
constitute  extremely  valuable  tools  until  the  impairment  of
the  bulbar-innervated  muscles  becomes  so  severe  that  they
become  ineffective.2,3 Thus,  the  muscles  which  cause  non-
invasive  ventilation  techniques  to  fail  are  not  the  thoracic
muscles  (as  inexperienced  doctors  might  suspect)  but  those
which  are  bulbar-innervated.  Patients  can  be  kept  alive  by
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eans  of  non-invasive  techniques  without  the  patient  being
equired  to  make  any  effort  to  breathe  or  cough,2--4 even
uring  episodes  of  pneumonia5 --  bulbar  impairment  permit-
ing.
To  achieve  this,  comprehensive  knowledge  of  the  avail-
ble  tools  and  their  use  is  necessary:  the  right  ventilators,
asks  of  various  types,  procedures  for  cough  capacity
ssessment  and  coughing  aids  where  necessary,  having
n  mind  that,  as  Dr  Escarrabill  wrote,6 ‘‘the  therapy
‘package’’  must  also  include  the  organisation  of  care’’.  A
ood  doctor  must  not  introduce  devices  too  early  into  the
ome  of  a  patient  nor  delay  this  unnecessarily;  patients  must
e  carefully  studied  in  order  to  ensure  that  they  receive  the
ost  effective  and  efﬁcient  treatment.  And  let  us  not  for-
et  that  very  few  patients  refuse  non-invasive  procedures,
hereas  the  percentage  of  patients  who  refuse  invasive
reatment  is  relatively  high.4 Therefore,  when  we  accept
he  responsibility  to  take  on  the  care  of  a  patient,  it  also
ecomes  our  responsibility  to  be  masters  of  the  techniques
hich  can  provide  support  to  the  respiratory  muscles.  When
peaking  of  such  expertise,  it  is  important  to  remember  that
hat  is  of  real  value  in  a  unit  for  ALS  patients  is  not  the  fact
hat  the  patient  may  be  visited  by  a  range  of  specialists  in
he  course  of  one  day.  Of  course,  such  co-ordination  is  of
nterest,  but  it  becomes  of  little  value  if  the  shift  schedule
s  such  that  these  patients  are  at  times  left  in  the  care  of
octors  with  little  or  no  expertise  in  non-invasive  ventilation
r  who  are  unaware  of  how  to  undertake  patient-centred,
nformed  decision-making.  Can  anyone  imagine  a  lung  trans-
lant  patient  being  treated  in  an  emergency  by  a  doctor  with
o  relevant  experience?When  non-invasive  procedures  fail,  there  are  two  alter-
atives,  which  the  patients  and  their  family  members  must
ave  been  able  to  consider  previously  in  good  time,  having
eceived  full  information  on  them:  tracheotomy  ventilation
lsevier España, S.L. All rights reserved.
1a
t
w
i
v
p
i
c
r
o
m
o
u
e
h
t
w
w
s
t
f
r
H
r
a
e
c
R
1
1
Spain78  
nd  comprehensive  palliative  care.1,4,7 Units  specialising  in
he  care  of  ALS  patients  must  be  able  to  provide  them
ith  both  of  these  options  at  excellent  standards  of  qual-
ty.  Doctors  should  not  begin  treatment  involving  mechanical
entilation  if  they  cannot  then  end  such  treatment  in  the
roper  manner,  if  this  is  the  patient’s  wish.8 We  must  min-
mise  the  suffering  of  patients  and  relatives.
This  edition  of  the  Rev  Port  Pneumol  makes  a  signiﬁcant
ontribution  to  knowledge  regarding  the  treatment  of  respi-
atory  problems  suffered  by  ALS  patients  thanks  to  the  work
f  a  group  of  experts  from  across  Europe.6,9,10 However,  we
ust  also  pay  tribute  to  the  work  of  someone  who  for  many
f  us  has  been  the  real  pioneer.  He  was  the  one  who  enabled
s  to  change  our  procedures  and  multiply  our  therapeutic
ffectiveness  while  minimising  treatment  side-effects.  We
ave  come  a  long  way  on  our  own  now,  but  we  must  ensure
hat  those  new  to  the  ﬁeld  understand  that  it  was  JR  Bach
ho  showed  us  the  way.
In  order  to  improve  treatment,  in  the  early  2000s  we
ould  often  stress  the  importance  for  the  presence  of  units
pecialising  in  the  respiratory  care  of  ALS  patients.11 Unfor-
unately,  until  very  recently,  the  lack  of  dedicated  resources
or  such  patients  was  still  a  common  complaint,  as  their
ights  to  be  treated  fairly  were  clearly  not  being  respected.1
owever,  things  are  changing.  The  proﬁle  of  ALS  patients  is
ising  in  both  medical  and  social  contexts  and  pulmonologists
re  showing  particular  interest  in  acquiring  the  right  knowl-
dge  and  skills  to  be  able  to  provide  them  with  high-quality
are.  This  journal  is  an  example  of  this  change.
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